Dec. 17 -- KaloBios Pharmaceuticals Inc. plummeted 50 percent in early trading after the drug company’s CEO Martin Shkreli was arrested in New York Thursday morning on securities fraud charges related to one of his prior companies. Bloombergs Keri Geiger reports on Bloomberg ‹GO›. (Corrects tense in headline.)
VideoDorks
BookDorks
AudioDorks
CssDorks
TVDorks
PhotoDorks
ThemeDorks